Rare diseases
Investigational molecules
Locations
1-8-2 Kyutaromachi, Chuo, 541-8564
Research activity centers on advanced colorectal cancer, with attention to tumors that are PD-L1 positive and not classified as MSI-H or dMMR. The therapeutic setting involves treatment-resistant disease in the gastrointestinal oncology space.
The sponsor’s interest in this area reflects work in solid tumor oncology focused on patients with advanced disease requiring systemic treatment options.
Ono Pharmaceutical Co. Ltd. runs clinical trials in conditions such as Colorectal cancer, among others.
Clinical trials run by this sponsor – those enrolling participants first.
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
